Loading...
Market
Outcomes of UnitedHealth CEO's testimony
5
Resolution / Starting Odds
CEO admits fault • 33%
CEO defends company protocols • 33%
CEO announces new initiatives • 33%
Official records from the hearing or major news reporting
Story
UnitedHealth's Change Healthcare Cyberattack: CEO to Testify, Data Compromised
Apr 22, 2024, 10:39 PM
UnitedHealth's Change Healthcare, a technology unit of the health insurance giant, was the target of a significant cyberattack that began on February 12, earlier than previously known. The breach, which involved compromised credentials, allowed hackers to access a remote-access application and resulted in a month-long disruption of payments to healthcare providers. Congressional leaders held a hearing on the same day as UnitedHealth's earnings call to address the incident. UnitedHealth confirmed that it paid a ransom to the hackers and that the attack compromised the health data of a substantial proportion of Americans. The U.S. Department of Health and Human Services reported a 278% increase in large ransomware breaches in the healthcare sector from 2018 to 2022. The UnitedHealth CEO is scheduled to testify before the US House Panel regarding the cyberattack.
View original story
Similar markets
CEO criticized by committee • 33%
CEO commended for handling of situation • 33%
Inconclusive or mixed outcome • 34%
Increase by more than 5% • 25%
Increase by less than 5% • 25%
Decrease by less than 5% • 25%
Decrease by more than 5% • 25%
UnitedHealth found at fault • 33%
UnitedHealth partially at fault • 33%
UnitedHealth not at fault • 33%
Cybersecurity Overhaul • 25%
Partnership with Cybersecurity Firm • 25%
Leadership Reshuffle • 25%
Settlement of Legal Claims • 25%
Significant investment in cybersecurity • 33%
Moderate changes to cybersecurity measures • 33%
No major changes announced • 34%
Less than $1 billion • 25%
$1 billion to $1.5 billion • 25%
$1.6 billion to $2 billion • 25%
More than $2 billion • 25%
Full cooperation • 25%
Partial cooperation • 25%
Non-cooperation • 25%
Legal challenge against the inquiry • 25%
Under $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $1.5 billion • 25%
Over $1.5 billion • 25%
Increased Regulatory Oversight • 33%
No Significant Action • 33%
Mandatory Safety Modifications Required • 33%